November 23rd 2024
A systematic review has found a potential link between edentulism and sleep apnea risk, although the authors said differences in study designs prohibited a meta-analysis.
Dr Robert Sidbury on Mental Health Implications of Atopic Dermatitis
April 28th 2022Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital, spoke on the mental health comorbidity risk linked with atopic dermatitis and how dermatologists can play a role in managing behavioral care needs of at-risk patients.
Watch
CLS Use Proved Superior at Reducing Adverse Outcomes in T1D vs Control Therapies
April 27th 2022This systematic review and meta-analysis used a literature search to gather data from long-term randomized controlled trials on the effectiveness of closed-loop insulin systems (CLS) among nonpregnant patients with type 1 diabetes (T1D).
Read More
NT-proBNP Level May Influence HF Risk Among Blacks vs Whites, Men vs Women
April 27th 2022In this new subanalysis of data from the Atherosclerosis Risk in the Communities study, investigators assessed the risk of incident heart failure (HF) or death by race and sex, as influenced by N-terminal pro–B-type natriuretic peptide (NT-proBNP) concentration, prompted by growing interest in its use as a predictive biomarker for HF.
Read More
Advocating for All Patients With Chronic Kidney Disease
April 26th 2022Chronic kidney disease is the fastest-growing noncontagious disease in the United States. On this episode of Managed Care Cast, we speak with Mike Spigler, vice president of patient support and education for the American Kidney Fund, who is spearheading the Unknown Causes of Kidney Disease Project, which aims to help underserved patients get to the root cause of their kidney disease, while also helping to solve this mystery for a broader patient population.
Listen
USPSTF Updates Preventive Aspirin Use Recommendation in CVD, CRC
April 26th 2022There may be a small, but not overwhelming, benefit for certain individuals aged 40 to 59 years who have a slightly elevated risk of future cardiovascular disease (CVD) to start taking aspirin, according to an update released by the US Preventive Services Task Force (USPSTF).
Read More
Elevated prevalence of post-traumatic stress disorder seen in family members of patients with COVID-19 treated in intensive care units; 9 rare respiratory cancers linked with burn pit exposure among veterans; adenovirus suggested as potential cause of unexplained cases of pediatric hepatitis.
Read More
Surveyed Patients Identify Unmet Needs in CRS With Nasal Polyps
April 23rd 2022Patients with chronic rhinosinusitis (CRS) with nasal polyps identified several unmet needs regarding their condition, particularly a lack of public and physician awareness on disease burden and poor sleep quality.
Read More
Novel Internet-Based Hospital-to-Home Model for Nutritional Nursing Effective in Patients With CKD
April 23rd 2022Continual nutrition modification is crucial in patients with moderate to advanced chronic kidney disease (CKD), and more interactive at-home solutions hold potential to improve nutritional nursing models after hospital discharge.
Read More
Use of CSII Linked to Lower Rates of DEB Among Children With T1D
April 23rd 2022This new study investigated and compared the incidence of disordered eating behavior (DEB) among 2 cohorts of patients with type 1 diabetes (T1D) treated with continuous-subcutaneous insulin infusion (CSII) or a basal-bolus regimen.
Read More
Contributor: How Chronic Care Management Could Be the Great Equalizer for Care
April 23rd 2022By creating a framework for social determinants of health that explores patients’ needs and prioritizes team members’ response, specialty practices can more effectively strengthen health equity, access to care, and health outcomes.
Read More
Changes in Use of Low-Value Services During the COVID-19 Pandemic
April 22nd 2022Use of low-value care services during COVID-19 exhibits substantial heterogeneity but, on average, shows declines similar to the use of high-value services; low-value care use lags behind high-value care use in the rebound phase.
Read More
Dr Stephen Rozzo Discusses Real-world Efficacy of Tildrakizumab for Psoriasis
April 22nd 2022Stephen Rozzo, PhD, associate vice president and head, Biologics Medical Affairs, Sun Pharma, North America, discussed findings of 2 phase 4 real-world studies on tildrakizumab, which showed that patients achieved significant improvement in severity and quality of life by week 4 of treatment.
Watch
Lack of Awareness, Cultural Barriers Impact Racial, Ethnic Groups Hit Hardest by SLE, CLE
April 21st 2022Patient education is an important step toward improving outcomes for racial and ethnic groups disproportionately affected by lupus, but a new report suggests payers and physicians also have more to learn about the problem.
Read More
Study Examines Impact of Biologics for Asthma on HCRU
April 21st 2022The research, conducted in Germany, found that biologic treatment for asthma resulted in reduced health care resource utilization (HCRU), as seen in fewer hospitalizations and oral corticosteroid prescriptions as well as less sick leave.
Read More
Breast MRI Linked to Greater Downstream Service Use, Costs vs Mammography
April 20th 2022This investigation focused on use of additional services and incidence of new diagnoses among women who underwent a breast cancer screening MRI—having a low or average risk of the cancer—compared with a matched cohort who underwent mammography.
Read More
Dr Elaine Siegfried on Considerations for Systemic Therapy Use in Pediatric Atopic Dermatitis
April 20th 2022Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, discusses several pediatric patient populations with atopic dermatitis who are candidates for the use of systemic therapies.
Watch
Ixekizumab Effective Long-term for Treatment of Psoriasis in Pediatric Patients
April 20th 2022Pediatric patients with psoriasis exhibited significant improvements in self-reported outcomes and objective measures of complete skin clearance when treated with ixekizumab vs placebo, with no new safety findings identified.
Read More
Spotlighting Health-, Cost-Related Benefits of Genomic Testing and How Employers Can Drive Adoption
April 20th 2022Key opinion leaders addressed cost, accessibility, and other barriers limiting use of comprehensive genomic profiling (CGP), and how employers can help drive preventive care and precision medicine through CGP.
Read More
How Can the Health Care Industry Help Tackle Climate Change?
April 19th 2022In a talk presented by The Hastings Center, Gary Cohen, president of Health Care Without Harm, explains how the health care industry can fight climate change, mitigate social determinants of health, and reduce costs through a series of targeted efforts.
Read More
Major Study Expands in Hopes to Cure Parkinson Disease
April 19th 2022April is Parkinson’s Disease Awareness month, and on this episode of Managed Care Cast, we take a look at the Parkinson's Progression Markers Initiative (PPMI), a study from the Michael J. Fox Foundation for Parkinson's Research (MJFF). The multicenter, international study aims to end Parkinson disease, which is expected to double worldwide by 2040, to more than 14 million people.
Listen
Long-term Cardiac-Related Mortality Likely Predicted by 30-Day Postsurgical Outcomes
April 18th 2022This study investigated long-term cardiac-related mortality as it relates to incidence of perioperative adverse cardiac events (excluding death) in the first 30 days after surgery among a short of patients who underwent non–cardiac-related surgery.
Read More